Acalabrutinib、Avatrombopag Maleate、Avapritinib、Daprodustat、Fezolinetant、Fruquintinib、Gefapixant citrate、Larotrectinib Sulfate、Mirogabalin Besylate、Niraparib Tosylate Monohydrate、Omarigliptin、Roxadustat、Resmetirom、
Sparsentan、Selpercatinib、Tofacitinib Citrate、Tirzepatide、Upadacitinib Hemihydrate、Vandetanib、Zuranolone and so on; 1-Bromodibenzo[b,d]furan、Dibenzo[b,d]furan-1-ylboronic acid、1-Dibenzofuranamine、1-(3-Bromophenyl)dibenzo[b,d]furan、2,4-Dichloro-6-(1-dibenzofuranyl)-1,3,5-triazine、2-Chloro-4-(dibenzo[b,d]furan-1-yl)-6-phenyl-1,3,5-triazine、3-Bromobenzo(b)naphtho(2,3-d)furan、2-Bromoindolo[3,2,1-jk]carbazole、5-Bromoindolo[3,2,1-jk]carbazole、2-Bromobenzo[9,10]phenanthrene、2-Chloro-4,6-diphenyl-1,3,5-triazine、2,3,5,6-Tetrafluoro-7,7,8,8-tetracyanoquinodimethane,F4-TCNQ and so on
more >
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights: